BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mason EO Jr, Lamberth LB, Wald ER, Bradley JS, Barson WJ, Kaplan SL. In vitro activities of cethromycin (ABT-773), a new ketolide, against Streptococcus pneumoniae strains that are not susceptible to penicillin or macrolides. Antimicrob Agents Chemother 2003;47:166-9. [PMID: 12499186 DOI: 10.1128/AAC.47.1.166-169.2003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Conte JE Jr, Golden JA, Kipps J, Zurlinden E. Steady-state plasma and intrapulmonary pharmacokinetics and pharmacodynamics of cethromycin. Antimicrob Agents Chemother 2004;48:3508-15. [PMID: 15328118 DOI: 10.1128/AAC.48.9.3508-3515.2004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
2 English ML, Fredericks CE, Milanesio NA, Rohowsky N, Xu ZQ, Jenta TR, Flavin MT, Eiznhamer DA. Cethromycin versus clarithromycin for community-acquired pneumonia: comparative efficacy and safety outcomes from two double-blinded, randomized, parallel-group, multicenter, multinational noninferiority studies. Antimicrob Agents Chemother 2012;56:2037-47. [PMID: 22290969 DOI: 10.1128/AAC.05596-11] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
3 Van Bambeke F, Reinert RR, Appelbaum PC, Tulkens PM, Peetermans WE. Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options. Drugs 2007;67:2355-82. [PMID: 17983256 DOI: 10.2165/00003495-200767160-00005] [Cited by in Crossref: 80] [Cited by in F6Publishing: 74] [Article Influence: 5.7] [Reference Citation Analysis]
4 Jorgensen JH, Crawford SA, McElmeel ML, Whitney CG. Activities of cethromycin and telithromycin against recent North American isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 2004;48:605-7. [PMID: 14742216 DOI: 10.1128/AAC.48.2.605-607.2004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
5 Perry CM, Scott LJ. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections. Drugs 2004;64:1433-64. [PMID: 15212560 DOI: 10.2165/00003495-200464130-00004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
6 Labro MT, Abdelghaffar H, Babin-Chevaye C. Interaction of the new ketolide ABT-773 (cethromycin) with human polymorphonuclear neutrophils and the phagocytic cell line PLB-985 in vitro. Antimicrob Agents Chemother 2004;48:1096-104. [PMID: 15047507 DOI: 10.1128/AAC.48.4.1096-1104.2004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]